D-serine treatment for neurological disorders that cause seizures
Abstract:
Methods of treatment using D-serine to target brain cells expressing GluN3 subunit-containing triheteromeric NMDARs are disclosed. The methods include inhibiting calcium ion uptake by brain cells, treating epilepsy, and treating seizures by artificially administering D-serine.
Public/Granted literature
Information query
Patent Agency Ranking
0/0